As this year comes to an end Thomas Kahan will be passing the Presidency of the ISCP over to Sang-Hong Baek in 2023, his message is below.
Congratulations to Gheorghe-Andrei Dan, and the rest of the organising committee (Thomas Kahan, Juan Carlos Kaski, Koji Hasegawa, Antoni Martinez-Rubio) as well as the Scientific Committee for running a successful ISCP Scientific Meeting in Bucharest. Planning is underway for the 28th Annual Scientific Meeting which will be held in conjunction with the KSCVP 2023 and KSCP 2023 in Seoul, Republic of Korea on 25-26 November 2023. Save the dates!
Please forward any news or information on upcoming conferences or meetings that you would like included in the March 2023 Newsletter to me at email@example.com by 22 February 2023.
Wishing you all a safe and happy festive season.
Editors: John McNeil & Lisa Demos
Message from our President
Time flies and the year 2022 is coming to an end and with it my term as President. This is the time to share news with you and thank those of you who have helped the Society over the last year.
We had the pleasure of being able to hold our Annual Scientific Meeting in Bucharest (Romania), and the hybrid format of the meeting also allowed participation online for many of those unable to travel and take part on-site. I am most grateful to our Director Professor Gheorghe-Andrei Dan and his team for organising such a successful meeting.
The COVID-19 pandemic and the sad global geopolitical situation have made us all adopt to more on-line activities during the last few years. Also, here the ISCP has been very successful, and the Society has continued the series of high-quality educational webinars. I would like to thank our Director, Associate Professor Doreen Tan for the excellent leadership, together with the many Directors and Governors who participated in these important activities.
I am also proud of the official journal of our Society, the European Cardiology Review, under the leadership of our Directors Professors Juan Carlos Kaski (Editor in Chief) and Pablo Avanzas (Deputy Editor). This journal is a most valuable means for our members and for the Society to communicate with the medical scientific community and make the voice of the ISCP well heard.
Our members are our Society, and the Governors are important catalysts of many activities of the Society. It is therefore a pleasure to welcome several new Governors to the ISCP this year. This will help our efforts to continue to provide education for cardiovascular pharmacotherapy at a high level in the coming year.
To close, I wish our Director and President-Elect, Professor Sang Hong Baek all success in taking over the leadership of the ISCP for 2023, and, of greatest importance, both he and I, on behalf of the Board of Directors of ISCP, wish you and your families a happy Holiday Season and a peaceful New Year.
Thomas Kahan, ISCP President
Sang Hong Baek, ISCP President Elect
The General Assembly of the ISCP was held on the 27th October 2022. It took place during the Annual Scientific Meeting in Bucharest and a report on the activities of the Society was presented to those attending. The Board of Directors for 2023 was approved as unchanged from 2022. The President for 2023` was confirmed as Professor Sang Hong Baek and the nomination of Professor Alberto Lorenzatti as President-Elect 2023 was approved and confirmed. A full list of the ISCP Board can be seen on the website.
2022 Annual Scientific Meeting
The 27th Annual Scientific Meeting of the ISCP was held 27-29 October 2022 in Bucharest, Romania with both on-site and online participants. This included a pre-congress course which was a joint initiative between the ISCP and ESC ACNAP (Association of Cardiovascular Nursing and Allied Professionals).
The ISCP Scientific Meeting and the pre-congress course included 40 international key opinion leaders. The Henry N Neufeld Lecture was presented by Milton Packer. Congratulations to the Young Investigator Award Joint First winners, Núria Mallofré (Spain) and Diana Andreea Ionescu (Romania), and to the runner-up Gusi Tragant (Spain).
New Governors: We welcome Rodrigo Alonso (Chile) andSurakit Nathisuwan (Thailand), as new ISCP Governors in 2022. A further group of new members and Governors are joining ISCP and will start their roles in the new year. Their nominations will be announced on our website and on social media, so please keep an eye out for the news coming out soon.
ISCP Endorsed meetings: 16 meetings were endorsed by the ISCP Meetings Committee in 2022. Theyincluded a video series on Targeting Inflammation in Atherosclerosis; and Novel Pharmacological Treatments for the Prevention of Cardiovascular Events; Meeting Real-world Challenges in Hypercholesterolaemia Management: Insight from a Pan-European Crowdsourcing Activity; Heart Failure Management in a Changing Paradigm roundtable discussions and the programme on Acute Coronary Syndrome (ACS) held at the ESC Congress 2022.
Webinars: A to Z of CV Pharmacotherapy series, in collaboration with Radcliffe Cardiology, have included the latest Clopidogrel or Ticagrelor Why When and for Whom? Presenters: Craig Beavers, Diana Gorog; Valsartan Sacubitril: Has our PARADIGM shifted? Presenters: Doreen Su-Yin Tan, Janice Wong Yii Ching; Edoxaban: ENGAGEing in Individualisation of DOACs Presenters: Doreen Su-Yin Tan, Gheorghe-Andrei Dan. The next webinar on 8 February 2023 will be on Nebivolol: No limb pain? Please note that all webinars in the A to Z series are CME EBAC accredited when attended live. 1 CME credit will be granted upon confirmation of successful attendance.
ISCP Statement on the war in Ukraine
The ISCP condemns the military aggression put forward by the leadership of the Russian Federation against Ukraine. With strong support from our colleagues, the ISCP urges for the aggression to cease and any conflict to be resolved on peaceful terms.
The continued aggression against Ukraine by the leadership of the Russian Federation and Belarus has led the ISCP to temporarily exclude individuals based in the Russian Federation or in Belarus from active participation in any ISCP event or activity, including those being offered exclusively with a full membership.
The ISCP very much regrets the effect this may have on physicians and allied healthcare professionals based in the Russian Federation and in Belarus. This should not be viewed as personal retaliation. However, the message to the leadership in these countries must be distinct and unequivocal.
News from World Heart Federation (WHF)
WHF Global Study on COVID-19 and CVD: sub-study published in the journal Heart
World Heart Observatory: launched by WHF on 1 February 2022 as a collaborative platform that collates high-quality data from different sources to provide the most reliable information related to cardiovascular conditions, risk factors, and interventions.
World Heart Highlights 2022: provides a quick overview of WHF joint achievements
New WHF Roadmap for Digital Health in Cardiology: launched on 27 August at a joint ESC-WHF session at the ESC Congress
WHF Roadmap for Secondary Prevention of Cardiovascular disease Consultation 2022: this survey will help to update the roadmap.
ISCP Book Series: Current Cardiovascular Therapy
The Current Cardiovascular Therapy Series provides both an in-depth view of the science and pharmacology behind these drugs and a practical guide to their usage. Each volume contains practical illustrations and is designed to improve understanding and practical usage of cardiovascular drugs in specific clinical areas.
The Springer series includes 9 books available as e-books or in softcover at a discounted rate for ISCP members. These include: Antiplatelet and Anticoagulation Therapy; Pharmacological Treatment of Acute Coronary Syndromes; Atrial Fibrillation Therapy; Cardiac Drugs in Pregnancy; Pharmacotherapy in Aortic Disease; Pharmacologic Trends of Heart Failure; Pharmacological Treatment of Chronic Stable Angina Pectoris; ACEi and ARBS in Hypertension and Heart Failure; Treatment of Pulmonary Hypertension.
European Cardiology Review (ECR) – Official ISCP Journal
The European Cardiology Review (ECR) is a PubMed indexed, peer-reviewed, gold open access journal comprising balanced review articles, systematic reviews, expert opinions and editorials. The journal is led by Editor-in-Chief Juan Carlos Kaski, along with Deputy Editor Pablo Avanzas and is supported by an editorial board of world-renowned physicians.
ECR volume 17 is available here with all articles free to read and download via the journal website. Recent articles include: Chest Pain in the Cancer Patient; and Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Obstructive Sleep Apnoea in Patients with Cardiovascular Disease.
If you are interested in becoming involved in the journal whether as an author, reviewer or board member, please contact Mandy Webb, Publisher, firstname.lastname@example.org.
Upcoming Meetings, Courses and Workshops
New Orleans, LA, USA
4 – 6 March 2023
19 – 21 May 2023
We are using the platforms below more frequently and all-important news and updates on new courses and events will be announced through those channels so in order to keep up to date please FOLLOW US!
- LinkTree https://linktr.ee/iscpcardio
- Twitter https://twitter.com/ISCPcardio
- LinkedIn https://www.linkedin.com/company/international-society-of-cardiovascular-pharmacotherapy/
- Facebook https://www.facebook.com/iscpcardio/
- YouTube https://www.youtube.com/@iscpcardio